Abstract :

Orofacial bone defects, particularly alveolar bone loss, are hallmark features of periodontal disease and represent a significant clinical challenge affecting oral function and quality of life. Interleukin-1β (IL-1β) has emerged as a key pro-inflammatory cytokine mediating the link between periodontal inflammation and osteoclastic bone resorption. This scoping review using keywords related to orofacial bone defects, alveolar bone loss, and IL-1β, published between 2016 and 2026. The studies included experimental models, animal studies, and clinical observations. Results consistently indicate that ligature induced periodontitis and microbial dysbiosis upregulate IL-1β expression, correlating with enhanced alveolar bone resorption. Interventions such as desipramine, epigallocatechin-3-gallate (EGCG), curcumin, and four-day fermented milk kefir demonstrated reductions in IL-1β levels alongside attenuated alveolar bone loss, highlighting the functional role of IL-1β in periodontal bone destruction. Immune modulation studies, including TLR-activated B10 cell transfer and Ifi204-deficient mouse models, further suggest that IL-1β–mediated osteoclast activity contributes directly to alveolar bone resorption independently of certain bone marrow–derived immune cell responses. Mechanistically, IL-1β promotes osteoclastogenesis via upregulation of RANKL and matrix metalloproteinases while downregulating tissue inhibitors of metalloproteinases. Collectively, the findings underscore IL-1β as a pivotal mediator in periodontitis-related bone loss and as a promising therapeutic target. Understanding these IL-1β mediated pathways informs the development of novel anti-inflammatory and regenerative strategies to improve oral and dental health outcomes.

---

Keywords :

cytokine, interleukin-1β, Orofacial bone defect, periodontal disease

---

References :

1. Florencio-Silva, R.; Sasso, G. R. da S.; Sasso-Cerri, E.; Simões, M. J.; Cerri, P. S. Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells. BioMed Res. Int. 2015, 2015, 421746. https://doi.org/10.1155/2015/421746.
2. Grünewald, T. A.; Johannes, A.; Wittig, N. K.; Palle, J.; Rack, A.; Burghammer, M.; Birkedal, H. Bone Mineral Properties and 3D Orientation of Human Lamellar Bone around Cement Lines and the Haversian System. IUCrJ 2023, 10 (Pt 2), 189–198. https://doi.org/10.1107/S2052252523000866.
3. Cowan, P. T.; Launico, M. V.; Kahai, P. Anatomy, Bones. In StatPearls; StatPearls Publishing: Treasure Island (FL), 2024.
4. Ikeuchi, T. and Moutsopoulos, N.M. (2022) Osteoimmunology in periodontitis: a paradigm for Th17/IL-17 inflammatory bone loss, Bone, 163, 116500. https://doi.org/10.1016/j.bone.2022.116500
5. Yu, H., Sun, C. and Argraves, K.M. (2016) Periodontal inflammation and alveolar bone loss induced by Aggregatibacter actinomycetemcomitans is attenuated in sphingosine kinase 1-deficient mice, Journal of Periodontal Research, 51(1), pp. 38–49. https://doi.org/10.1111/jre.12276
6. Branco-de-Almeida, L.S., Franco, G.C.N., Castro, M.L., Vieira, M.S., Galvão-Moreira, L.V., Cortelli, S.C., Anbinder, A.L., Kawai, T. and Rosalen, P.L. (2020) Protective effects of desipramine on alveolar bone in experimental periodontitis, Journal of Periodontology, 91(12), pp. 1694–1703. https://doi.org/10.1002/JPER.19-0569
7. Wang, Y., Yu, X., Lin, J., Hu, Y., Zhao, Q., Kawai, T., Taubman, M.A. and Han, X. (2017) B10 cells alleviate periodontal bone loss in experimental periodontitis, Infection and Immunity, 85(9), e00335-17. https://doi.org/10.1128/IAI.00335-17
8. Swanson, K.V., Girnary, M., Alves, T., Ting, J.P.Y., Divaris, K., Beck, J., Pucinelli, C.M., da Silva, R.A.B., Uyan, D., Wilson, J., Seaman, W.T., Webster-Cyriaque, J., Vias, N., Jiao, Y., Cantley, L., Marlier, A., Arnold, R.R. and Marchesan, J.T. (2023) Interferon activated gene 204 (Ifi204) protects against bone loss in experimental periodontitis, Journal of Periodontology
9. Fan, Q., Zhou, X.-H., Wang, T.-F., Zeng, F.-J., Liu, X., Gu, Y., Chen, B., Yang, J., Pang, Z.-Y., Liu, J.-G. and Bai, G.-H. (2023) Effects of epigallocatechin-3-gallate on oxidative stress, inflammation, and bone loss in a rat periodontitis model, Journal of Dental Sciences, 18(4), pp. 1567–1575
10. Sha, A.M., Garib, B.T., Azeez, S.H. and Gu, S.S. (2021) Effects of curcumin gel on osteoclastogenic bone markers in experimental periodontitis and alveolar bone loss in Wistar rats, Journal of Dental Sciences, 16, pp. 905–914. https://doi.org/10.1016/j.jds.2020.09.015
11. Vieira, L.V., de Sousa, L.M., Maia, T.A.C., Gusmão, J.N.F.M., Goes, P., Pereira, K.M.A., Miyajima, F. and Gondim, D.V. (2021) Milk kefir therapy reduces inflammation and alveolar bone loss in periodontitis in rats, Biomedicine & Pharmacotherapy, 139, 111677. https://doi.org/10.1016/j.biopha.2021.111677
12. Cheng, R., Wu, Z., Li, M., Shao, M. and Hu, T. (2020) Interleukin-1β is a potential therapeutic target for periodontitis: a narrative review, International Journal of Oral Science, 12, Article number 2. https://doi.org/10.1038/s41368-019-0068
13. Bord S, Horner A, Hembry R, Reynolds J, Compston J. Production of collagenase by human osteoblasts and osteoclasts in vivo. Bone 1996;19:35e40.
14. Deshpande N, Deshpande A. Immunoregulation in periodontal disease. Indian J Dent 2013;4:35e7